Citigroup

Selected news for the capital firm - Citigroup, collected since 10/2017. Recent stories appear in Daily Political and zolmax.com. This capital firm shares healthcare news with Medical Research, UnitedHealth, UnitedHealth Group, Gilead Sciences, Amgen and hundreds of others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
5/9/2021 Baxter International (NYSE:BAX) Given New $98.00 Price Target at Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell | Daily Political Daily Political Baxter International (NYSE:BAX) had its price target increased by Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell from $94.00 to $98.00 in a research note issued to investors on Thursday, Benzinga reports. They currently have a buy rating on the medical instruments supplier’s stock.Several other research analysts have also commented on the company. UBS Group lowered Baxter International from a buy rating to a neutral rating ...
5/9/2021 Baxter International (NYSE:BAX) Price Target Raised to $98.00 zolmax.com Baxter International (NYSE:BAX) Price Target Raised to $98.00 Posted by Stuart HamBaxter International (NYSE:BAX) had its target price boosted by Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell from $94.00 to $98.00 in a research report released on Thursday morning, Benzinga reports. Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell currently has a buy rating on the medical instruments supplier’s stock.Other ...
5/8/2021 Royal Bank of Canada Raises Universal Health Services (NYSE:UHS) Price Target to $160.00 slatersentinel.com ... of America cut shares of Universal Health Services from a neutral rating to an underperform rating and set a $144.00 price objective for the company. in a research report on Tuesday, January 5th. Finally, Citigroup lowered their price target on shares of Universal Health Services from $162.00 to $151.00 in a research report on Tuesday, March 2nd. Two research analysts have rated the stock with a sell rating, three have ...
5/8/2021 Royal Bank of Canada Boosts Universal Health Services (NYSE:UHS) Price Target to $160.00 rivertonroll.com ... have also recently weighed in on UHS. JPMorgan Chase & Co. restated a sell rating and issued a $115.00 price target on shares of Universal Health Services in a research note on Sunday, March 14th. Citigroup decreased their target price on Universal Health Services from $162.00 to $151.00 in a research report on Tuesday, March 2nd. Deutsche Bank Aktiengesellschaft raised their target price on shares of Universal Health Services from $145.00 ...
5/8/2021 Bunge Announces Pricing of Senior Notes Offering | Business Wire Business Wire ... satisfaction of customary closing conditions.Bunge intends to use the net proceeds from the offering of the senior notes for general corporate purposes, including repayment of certain short-term indebtedness.Goldman Sachs & Co. LLC, Citigroup Global Markets Inc., J.P. Morgan Securities LLC, Wells Fargo Securities, LLC and SMBC Nikko Securities America, Inc. are acting as joint book-running managers for the offering of senior notes. BBVA Securities Inc., BMO Capital ...
5/8/2021 Bunge Announces Pricing of Senior Notes Offering itbusinessnet.com ... satisfaction of customary closing conditions.Bunge intends to use the net proceeds from the offering of the senior notes for general corporate purposes, including repayment of certain short-term indebtedness.Goldman Sachs & Co. LLC, Citigroup Global Markets Inc., J.P. Morgan Securities LLC, Wells Fargo Securities, LLC and SMBC Nikko Securities America, Inc. are acting as joint book-running managers for the offering of senior notes. BBVA Securities Inc., BMO Capital ...
5/8/2021 SVB Leerink Equities Analysts Raise Earnings Estimates for Silk Road Medical, Inc (NASDAQ:SILK) dispatchtribunal.com ... research analysts have also recently issued reports on SILK. Zacks Investment Research raised shares of Silk Road Medical from a “sell” rating to a “hold” rating in a research note on Wednesday. Citigroup lowered their target price on shares of Silk Road Medical from $64.00 to $59.00 in a research note on Tuesday, March 2nd. Three investment analysts have rated the stock with a hold rating and two ...
5/8/2021 OraSure Technologies (NASDAQ:OSUR) Stock Price Up 6.7% After Better-Than-Expected Earnings - Watch List News watchlistnews.com ... reports on the stock. Raymond James reduced their price target on shares of OraSure Technologies from $16.00 to $12.00 and set an “outperform” rating on the stock in a research report on Thursday. Citigroup reduced their price target on shares of OraSure Technologies from $18.00 to $16.00 in a research report on Tuesday, March 2nd. Lake Street Capital dropped their price objective on shares of OraSure Technologies from $24.00 ...
5/8/2021 Ortho Clinical Diagnostics (NASDAQ:OCDX) Hits New 1-Year High After Analyst Upgrade rivertonroll.com ... as $21.20 and last traded at $21.00, with a volume of 7221 shares trading hands. The stock had previously closed at $20.49.Several other equities analysts have also recently weighed in on the stock. Citigroup started coverage on shares of Ortho Clinical Diagnostics in a research note on Monday, February 22nd. They issued a “buy” rating and a $20.00 target price for the company. Morgan Stanley upped their target ...
5/8/2021 Q2 2021 Earnings Forecast for NuVasive, Inc. Issued By Piper Sandler (NASDAQ:NUVA) com-unik.info ... a $80.00 price objective on the stock. Piper Sandler also issued estimates for NuVasive’s Q2 2022 earnings at $0.59 EPS. Get NuVasive alerts:Other equities analysts also recently issued reports about the stock. Citigroup upped their price target on shares of NuVasive from $68.00 to $80.00 in a research note on Thursday, March 25th. Zacks Investment Research upgraded shares of NuVasive from a “sell” rating to a “hold ...
5/8/2021 Jefferies Financial Group Equities Analysts Increase Earnings Estimates for Laboratory Co. of America Holdings (NYSE:LH) zolmax.com ... Financial Group also issued estimates for Laboratory Co. of America’s FY2021 earnings at $22.62 EPS. Get Laboratory Co. of America alerts:Other research analysts have also recently issued research reports about the stock. Citigroup boosted their price objective on shares of Laboratory Co. of America from $278.00 to $312.00 in a research report on Monday, May 3rd. Argus raised shares of Laboratory Co. of America from a “hold” ...
5/8/2021 Lyft (NASDAQ:LYFT) PT Raised to $80.00 at Citigroup - Watch List News watchlistnews.com Lyft (NASDAQ:LYFT) had its price target upped by equities researchers at Citigroup from $76.00 to $80.00 in a research note issued on Thursday, The Fly reports. Citigroup’s target price points to a potential upside of 59.78% from the stock’s current price.Several other equities analysts also recently weighed in on LYFT. KeyCorp raised their target price on shares of Lyft from $55.00 to $57.00 and gave the ...
5/8/2021 ExlService (NASDAQ:EXLS) Raised to “Buy” at Zacks Investment Research zolmax.com ... Get ExlService alerts:A number of other research firms have also recently issued reports on EXLS. Robert W. Baird reaffirmed a hold rating on shares of ExlService in a report on Sunday, February 28th. Citigroup lifted their price objective on ExlService from $90.00 to $92.00 and gave the stock a neutral rating in a research report on Monday, March 8th. Finally, William Blair reiterated an outperform rating on shares of ...
5/8/2021 Clover Health Investments (NASDAQ:CLOV) Upgraded at Zacks Investment Research rivertonroll.com ... patients. Clover Health Investments Corp., formerly known as Social Capital Hedosophia Holdings Corp. III, is based in Calif. “ Get Clover Health Investments alerts:A number of other analysts have also commented on CLOV. Citigroup reduced their price objective on shares of Clover Health Investments from $19.00 to $13.00 in a research note on Wednesday, March 3rd. Credit Suisse Group began coverage on shares of Clover Health Investments in a ...
5/8/2021 Zacks Investment Research Lowers GW Pharmaceuticals (NASDAQ:GWPH) to Strong Sell Mayfield Recorder ... United Kingdom, Europe, the United States, Canada, and Asia. GW Pharmaceuticals plc is based in Salisbury, the United Kingdom. “ Get GW Pharmaceuticals alerts:GWPH has been the subject of several other research reports. Citigroup cut GW Pharmaceuticals from a “buy” rating to a “neutral” rating in a research note on Thursday, February 4th. HC Wainwright cut GW Pharmaceuticals from a “buy” rating to a “neutral” ...
5/8/2021 JPMorgan Chase & Co. Raises Position in Hookipa Pharma Inc (NASDAQ:HOOK) baseballnewssource.com ... worth $376,000 as of its most recent filing with the Securities & Exchange Commission.A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Citigroup Inc. increased its stake in Hookipa Pharma by 94.9% in the fourth quarter. Citigroup Inc. now owns 2,335 shares of the company’s stock valued at $26,000 after acquiring an additional 1,137 shares during the ...
5/8/2021 New York State Teachers Retirement System Has $2.57 Million Stock Holdings in Select Medical Holdings Co. (NYSE:SEM) Mayfield Recorder ... Medical by 22.8% during the 4th quarter. Schroder Investment Management Group now owns 91,228 shares of the health services provider’s stock worth $2,523,000 after purchasing an additional 16,967 shares in the last quarter. Citigroup Inc. increased its position in Select Medical by 67.3% during the 4th quarter. Citigroup Inc. now owns 68,920 shares of the health services provider’s stock worth $1,906,000 after purchasing an additional 27,735 shares in ...
5/8/2021 Bunge Announces Pricing of Senior Notes Offering itbusinessnet.com ... satisfaction of customary closing conditions.Bunge intends to use the net proceeds from the offering of the senior notes for general corporate purposes, including repayment of certain short-term indebtedness.Goldman Sachs & Co. LLC, Citigroup Global Markets Inc., J.P. Morgan Securities LLC, Wells Fargo Securities, LLC and SMBC Nikko Securities America, Inc. are acting as joint book-running managers for the offering of senior notes. BBVA Securities Inc., BMO Capital ...
5/8/2021 Baxter International (NYSE:BAX) Given New $98.00 Price Target at Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell - WKRB News wkrb13.com Baxter International (NYSE:BAX) had its price objective increased by equities research analysts at Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell from $94.00 to $98.00 in a report released on Thursday, Benzinga reports. The firm currently has a “buy” rating on the medical instruments supplier’s stock. Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell’s price target suggests a potential upside of 13.14 ...
5/8/2021 Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell Increases Baxter International (NYSE:BAX) Price Target to $98.00 Mayfield Recorder Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell Increases Baxter International (NYSE:BAX) Price Target to $98.00 Posted by Clark Linder on May 8th, 2021Baxter International (NYSE:BAX) had its price target boosted by research analysts at Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell from $94.00 to $98.00 in a report released on Thursday, Benzinga reports. The firm presently has a “buy” rating ...